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The Biosynthetic Gene Cluster for the Antitumor
Rebeccamycin: Characterization and Generation
of Indolocarbazole Derivatives
tumor drugs, which can be divided into two major groups
depending on their mechanisms of action and structural
features. One group consists of protein kinase inhibitors,
such as staurosporine and K-252a. Usually, they contain
a sugar moiety linked to both indole nitrogens of the
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cal trials for their use against several types of tumors [3].
Rebeccamycin (Figure 1) is an antitumor antibiotic
produced by the actinomycete Saccharothrix aeroco-Summary
lonigenes ATCC39243 [4, 5]. It shows antibacterial activ-
ity against several Gram-positive bacteria, includingRebeccamycin, a halogenated natural product of the
indolocarbazole family, is produced by Saccharothrix Staphylococcus aureus and Streptococcus faecalis. Re-
beccamycin also inhibits the growth of some tumor cellaerocolonigenes ATCC39243. Several rebeccamycin
analogues, which target DNA topoisomerase I or II, lines and displays activity against several types of tu-
mors implanted in mice [5]. There is a considerable efforthave already entered clinical trials as anticancer
drugs. Using as a probe an internal fragment of ngt, placed on the design and synthesis of new rebecca-
mycin analogs and derivatives with enhanced antitumora Saccharothrix aerocolonigenes gene encoding an
indolocarbazole N-glycosyltransferase, we isolated a activity [6]. From a different point of view, rebeccamycin
has also attracted interest because it is a halogenatedDNA region that directed the biosynthesis of rebec-
camycin when introduced into Streptomyces albus. natural product [7].
Despite the interest focused on indolocarbazoles,Sequence analysis of 25.6 kb revealed genes for indo-
locarbazole core formation, halogenation, glycosyla- very little is known about the biochemical and genetic
aspects of their biosyntheses. As far as we know, notion, and sugar methylation, as well as a regulatory
gene and two resistance/secretion genes. Heterolo- complete set of genes for the biosynthesis of an indolo-
carbazole natural product has been reported. A patentgous expression of subsets of these genes resulted in
production of deschloro-rebeccamycin, 4-demethyl- application has claimed the cloning of some genes
needed for the last steps in the biosynthesis of the staur-deschloro-rebeccamycin, and deschloro-rebec-
camycin aglycone. The cloned genes should help to osporine sugar moiety in Streptomyces longisporofla-
vus DSM10189 [8]. More recently, the cloning and se-elucidate the molecular basis for indolocarbazole bio-
synthesis and set the stage for the generation of novel quencing of a gene, ngt, encoding an indolocarbazole
N-glycosyltransferase from Saccharothrix aerocoloni-indolocarbazole analogues by genetic engineering.
genes ATCC39243 has been reported [9].
Here we report the cloning and sequencing of theIntroduction
complete gene cluster encoding rebeccamycin biosyn-
thesis from Saccharothrix aerocolonigenes ATCC39243.Since its discovery in 1977, the indolocarbazole family
of natural products has received great attention from We also show that the identified set of genes is neces-
sary and sufficient for rebeccamycin production by het-both organic chemists and biomedical researchers. The
reason for this interest resides in the novel structures erologous expression in Streptomyces albus. Finally, we
report the production of rebeccamycin derivatives inand wide range of biological activities (antibacterial, an-
tifungal, and antitumor) that members of this family dis- S. albus when transformed with selected subsets of the
identified genes.play [1]. Indolocarbazole natural products are defined
by their characteristic structure containing either in-
dolo[2,3-a]pyrrolo[3,4-c]carbazole (e.g., rebeccamycin),
Results and Discussionindolo[2,3-a]carbazole (e.g., tjipanazoles), or bis-indolyl-
maleimide (e.g., arcyriarubin) moieties. In particular, the
Isolation of the DNA Region Surroundingindolopyrrolocarbazoles constitute a new class of anti-
the ngt Gene
Recently, the Saccharothrix aerocolonigenes ATCC392433 Correspondence: jasf@sauron.quimica.uniovi.es (J.A.S., for molec-
ngt gene, encoding an N-glycosyltransferase able toular-biology communications) rohrj@musc.edu (J.R., for chemical
communications) introduce a D-glucose moiety into indolocarbazoles
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Figure 1. Structure of Rebeccamycin and
Derivatives
J-104303 and 6-N-methylarcyriaflavin C, has been firmed that they were identical to the sequence pre-
viously reported [11].cloned and sequenced [9]. No other open reading frame
(ORF) was reported in the sequenced region, encom-
passing 1898 nucleotides (nt). Given the known prece- Production of Rebeccamycin
in a Heterologous Hostdent that antibiotic biosynthetic genes commonly occur
as a cluster in antibiotic-producing actinomycetes, we In order to determine if any of the isolated cosmids
harboured the complete rebeccamycin gene cluster, weset out to isolate the DNA flanking ngt in order to identify
the rebeccamycin biosynthetic gene cluster. A Sacchar- independently introduced the cosmids into the heterolo-
gous host Streptomyces albus J1074 and analyzedothrix aerocolonigenes ATCC39243 genomic library was
constructed in the Escherichia coli-Streptomyces shut- transformants for production of rebeccamycin or any
biosynthetic precursor. We routinely use S. albus J1074tle vector pKC505 [10]. This library was screened with
a probe from an internal fragment of ngt, resulting in the as a host for heterologous gene expression and metabo-
lite production because this strain shows a nice, dis-isolation of several overlapping cosmids (10A4, 14E8,
17A12, and 24B2). It has been previously shown by PCR persed growth, a very low background concerning aro-
matic metabolite production (as detected by HPLC), andamplification that the genome of Saccharothrix aeroco-
lonigenes ATCC39243 contains at least one FADH2- a good efficiency of protoplast transformation. Two of
the cosmids (14E8 and 17A12) conferred the ability todependent halogenase gene [11]. In order to investigate
if this putative halogenase gene was part of the rebecca- produce a compound not produced by the host strain
S. albus J1074. The identity of this compound with re-mycin biosynthetic gene cluster, we analyzed the iso-
lated cosmids by PCR with degenerate oligoprimers de- beccamycin was demonstrated as follows. First, it
showed antibacterial activity in growth inhibition testssigned to amplify halogenase genes. A PCR product of
the expected size was amplified only from cosmids 14E8 performed on Micrococcus luteus. Second, it had the
same relative mobility as authentic rebeccamycin inand 17A12. The sequencing of these PCR products con-
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Table 1. 1H NMR data of rebeccamycin (1), deschlororebeccamycin (2), 4-demethyl-deschlororebeccamycin (3), and deschloro-
rebeccamycin aglycon (4) in d6-DMSO at 400 MHz
Compound
1 2 3 4
Position , Multiplicity (J/HZ) , Multiplicity (J/HZ) , Multiplicity (J/HZ) , Multiplicity (J/HZ)
1-H – 9.05 d (8) 9.04 d (8) 8.99 d (8)
2-H 7.66 d (8) 7.33 t (8) 7.33 t (8) 7.34 t (8)
3-H 7.44 t (8) 7.54 t (8) 7.50-7.57 t (8)a 7.54 t (8)
4-H 9.06 d (8) 7.68 d (8) 7.65 d (8) 7.80 d (8)
N6-H 11.34 s 11.37 s 11.06 s 10.96 s
8-H 9.24 d (8) 7.92 d (8) 7.93 d (9) 7.80 d (8)
9-H 7.44 t (8) 7.54 t (8) 7.50-7.57 dd (9,8)a 7.54 t (8)
10-H 7.72 d (8) 7.33 t (8) 7.33 t (8) 7.34 t (8)
11-H – 9.13 d (8) 9.12 d (8) 8.99 d (8)
N12-H – – – 11.77 s
N13-H 10.66 s 11.57 s 11.63 s 11.77 s
1-H 6.91 d (9) 6.26 d (9) 6.24 d (9) –
2-H 3.69 ddd (9,9,6) 3.52 ddd (9,9,5) 3.50 ddd (9,9,5)b –
2-OH 5.0 d (6) 4.93 d (5) 4.87 d (5) –
3-H 3.56 ddd (9.5,9,6) 3.69 ddd (9.5,9,6) 3.54 ddd (9,9,5)b –
3-OH 5.39 d (6) 5.24 d (6) 5.09 d (5) –
4-H 3.64 dd (9.5,9.5) 3.74 dd (9.5,9.5) 3.96 ddd (9.5,9.5,5) –
4-OH – – 5.34 d (5) –
4-OCH3 3.59 s 3.62 s – –
5-H 3.82 dt (9.5,5) 3.85 ddd (9.5,5,4) 3.78 ddd (9,4,2) –
6-H2 3.94 dd (6,5) 3.93 dd (11,4) 3.93 dd (11,2)c –
3.98 dd (11,5) 4.04 dd (11,4)
6-OH 5.27 t (6) 6.10 dd (5,4) 5.96 t (4) –
 is given in ppm relative to internal TMS.
a Complex, overlapping signals; J not exactly determinable.
b Overlapping signal assignments are interchangeable.
c Broad signal.
HPLC analysis under different chromatographic condi- The signals, typical for a sugar moiety (Tables 1 and
2, C1 to C6, 1-H to 6-H2) and in line with the observa-tions. Third, it showed the characteristic rebeccamycin
absorption spectrum with maxima at 238 and 316 nm. tions that the nitrogen atom at the 12 position lacks a
proton and that carbons 11a and 12a, adjacent to N-12,Fourth, the compound was purified and studied by high-
resolution EI-MS, yielding a main peak with a mass of are coupled to a proton of C1 of this glycoside residue,
confirm the presence of the sugar moiety and its569.0753 corresponding to rebeccamycin with theoreti-
cal calculated molecular mass of 569.0757 (for N-glycosidic linkage to N-12. The NMR data are close
to those reported earlier [4]. Thus, the combination ofC27H21N3O7Cl2), and a minor peak with a mass of 393
corresponding to rebeccamycin aglycone. Similar MS HSQC, HMBC, and DQCOSY NMR spectra along with
the MS data clearly showed the compound at hand toresults were previously reported for purified rebecca-
mycin [4]. Finally, the structure of the product was con- be rebeccamycin (1; Figure 1).
Rebeccamycin production levels in these S. albus re-firmed to be that of rebeccamycin by NMR analysis as
described below. combinant strains were several fold greater than those
obtained with Saccharothrix aerocolonigenes ATCC39243Rebeccamycin (1, Figure 1) was analyzed by 1D 1H
and 2D 1H, 13C NMR spectroscopy. The 13C, 1H HSQC grown in the same conditions. Cosmid 14E8, one of the
cosmids able to direct rebeccamycin biosynthesis, was(heteronuclear single quantum coherence) experiment
and a 2D 13C, 1H HMBC experiment allowed the detection chosen for further study.
It is known that rebeccamycin has antibacterial activ-and assignment of almost all carbons of the molecule
(Table 1). For instance, a distinctive proton signal with ity against some Gram-positive bacteria and that it pro-
duces a weak inhibition of growth against some Strepto- 11.36 couples to the carbons with  170.1 (C5 and C7),
123.3 (C7a), and 121.3 (C4c) and apparently belonged myces spp. [12]. Based on the frequent linkage between
biosynthetic and resistance genes, we decided to deter-to the N bound 6-H of rebeccamycin. The cross peaks
at 10.69/137.8, 10.69/130.4, and 10.69/118.3 tied the mine whether the cloned DNA contained rebeccamycin
resistance determinants. We checked the effect of exog-proton at N-13 to the corresponding carbons 13a, 12b,
and 4b of the pyrrole ring. An aromatic proton, part of enously added rebeccamycin on the growth of S. albus
J1074/14E8 and on that of the control strain S. albusan ABC system, with  9.09 (4-H) was strongly coupled
to the carbons with  values of 137.8 (C13a) and 127.8 J1074/pKC505. Paper disc diffusion assays showed that
growth of S. albus J1074/pKC505 was totally inhibited(C4a), and the 1H signal with  9.27 (8-H) gave intense
cross peaks with carbons possessing  138.2 (C11a) by 100 g rebeccamycin, whereas S. albus J1074/14E8
was not affected by amounts of as much as 200 g.and 130.7 (C7c).
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rebP, to be involved in indolocarbazole core formation.Table 2. 13C NMR data of rebeccamycin (1)a, deschloro-
rebeccamycin (2), 4-demethyl-deschloro-rebeccamycin (3), and Some experimental evidence for that assumption is also
deschloro-rebeccamycin aglycon (4) in DMSO-d6 at 100.6 MHz presented in this paper (see below). Previous reports
have shown that the indolocarbazole core of both rebec-Compound
camycin and staurosporine is biosynthesized from two
1a 2 3 4
units of L-tryptophan, with the carbon skeleton incorpo-
Position     rated intact [13, 14]. Moreover, indolepyruvic acid has
been identified as an intermediate of rebeccamycin bio-1 117.0 124.4 125.1 124.1
synthesis [15]. In agreement with this, the rebO gene2 130.4 120.4b 121.0b 120.1
3 123.1 126.9b 127.6b 126.6 product belongs to a family of flavin-containing amine
4 124.1 112.2 112.8b 111.9 oxidases, including L-amino acid oxidase AIP from the
4a 127.8 121.4b 122.1b 121.4 fish Scomber japonicus [16] and putative amine oxidase
4b 118.3 118.6b 119.1b 115.4
CC1091 from Caulobacter crescentus [17]. The protein4c 121.3 121.1b 121.3b 119.7
encoded by rebO could catalyze the first step in indolo-5 170.1 171.0 171.7 171.1
carbazole biosynthesis, the oxidative deamination of7 170.1 171.0 171.7 171.1
7a 123.3 119.4b 120.1b 119.7 L-tryptophan to yield indolepyruvic acid. Very recently,
7b 119.2* 116.9b 117.6b 115.4 it has been shown that feeding either 5-fluorotryptophan
7c 130.7 121.1b 121.7b 121.4 or 6-fluorotryptophan to cultures of Saccharothrix aero-
8 124.7 111.7 112.5b 111.9
colonigenes induces the production of novel fluorinated9 123.1 126.8b 127.4b 126.6
analogs of rebeccamycin [18]. This suggests that RebO10 128.1 120.6b 121.7b 120.1
may accept different tryptophan derivatives for oxida-11 117.0 124.4 125.1 124.1
11a 138.2 142.1 142.8 140.1 tive deamination.
12a 129.5c 128.2 129.0 128.9 The exact nature of intermediates and reactions be-
12b 130.4 129.6 130.4 128.9 tween indolepyruvic acid (or 7-chloro-indolepyruvic
13a 137.8 140.7 141.4 140.1
acid) and rebeccamycin aglycone is unknown, but a1 85.2 84.1 85.1 –
pathway including condensation of two tryptophan-2 72.9 73.1 73.2 –
derived units, several oxidations, and two decarboxyl-3 78.0 76.3 77.3 –
4 79.7 77.3 68.2 – ations seems plausible. Next we describe and discuss
4-OCH3 60.7 60.0 – – genes rebD, rebC, and rebP, probably responsible for
5 80.8 77.1 79.2 – these biosynthetic steps.
6 60.4 58.5 58.9 –
rebD encodes a protein that showed significant simi-
 is in ppm relative to internal TMS. Assignments were made with larities to two database proteins, VioB from Chromobac-
the help of couplings observed in the HSQC and HMBC spectra. terium violaceum [19, 20] and hypothetical protein
a Data from HSQC and HMBC spectra.
SC9A4.17 from Streptomyces coelicolor (accessionb Assignments are interchangeable within each group.
number CAC01644) [21]. VioB is involved in early stepsc Not observed by the indirect detection methods, taken from the
of the biosynthesis of violacein, a blue pigment whoseliterature ([4], 90 MHz) for comparison reasons.
carbon skeleton originates from two molecules of
L-tryptophan accompanying decarboxylation [19, 20]. It
has been speculated that VioB is a multifunctional en-
Analysis of the Rebeccamycin Biosynthetic zyme that catalyzes a 1,2-indole shift as well as a con-
Gene Cluster densation reaction between the two tryptophan (or tryp-
The complete DNA sequence of the insert contained in tophan-derived) units to generate the violacein pyrrole
cosmid 14E8 was determined to consist of 25,681 nt ring [19]. We propose that RebD performs a similar func-
(the sequence was deposited at the EMBL Nucleotide tion in rebeccamycin biosynthesis by condensing two
Sequence Database with accession number AJ414559). tryptophan-derived units (probably indolepyruvic acid
Sequence analysis revealed the presence of 16 com- or its 7-chlorinated form) to yield the first bis-indole
plete ORFs and two incomplete ORFs, whose organiza- intermediate. However, important functional differences
tion is shown in Figure 2A. Database comparisons al- between violacein and indolocarbazole biosynthetic en-
lowed us to propose functions for most of these ORFs zymes must exist. The non-indolic nitrogen in violacein
(Table 3). Genes apparently involved in rebeccamycin exclusively originates from one of the tryptophan units
biosynthesis seem to be organized in four transcriptional that is incorporated intact; the other tryptophan unit
units: rebG, rebODCPM, rebRFUH, and rebT. In operons somehow loses its -amino group and suffers an intra-
rebODCPM and rebRFUH, genes are translationally cou- molecular 1,2-indole shift [20]. On the other hand, the
pled, with rebM, whose start codon is only 26 nt away origin of the non-indolic nitrogen in indolocarbazoles
from rebP stop codon, as the only exception. Each of remains mysterious; it appears that the side-chain nitro-
these polycistronic transcriptional units ends with an gen in tryptophan is cleaved and not incorporated into
inverted repeat (nt 17,412–17,447, and nt 23,872– staurosporine [22].
23,927), which could lead to stem-loop secondary struc- As mentioned above, some genes needed for biosyn-
tures at the mRNA and transcription termination. thesis of the staurosporine sugar moiety in S. longispor-
Genes Probably Involved in Formation oflavus DSM10189 have been previously identified [8].
of the Indolocarbazole Core These authors reported 10 kb of contiguous DNA se-
Based on sequence analysis and database comparison, quence, deposited as three fragments with accession
numbers A60304, A60301, and A60305. However, a de-we propose a group of four genes, rebO, rebD, rebC, and
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Figure 2. The Rebeccamycin Gene Cluster
and Its Heterologous Expression
(A) Restriction map and genetic organization
of the Saccharothrix aerocolonigenes
ATCC39243 DNA region that includes the re-
beccamycin biosynthetic gene cluster (in
red). Proposed functions for individual ORFs
are summarized in Table 1. Sites for restric-
tion enzymes are abbreviated as follows: B,
BamHI; Bg, BglII; E, EcoRI; K, KpnI; S, ScaI;
and St, StuI.
(B) Schematic representation of inserts con-
tained in plasmids pREB5, pREB6, and
pREB7. A green arrow indicates the ermE*p
promoter included in pREB6.
tailed analysis of the complete DNA sequence was not sugar 3,5-epimerase); and (3) in accession number
A60305—no ORFs reported. Because we expected thatreported, and they identified only the following ORFs in
their patent application (but not in their database entry): rebeccamycin and staurosporine gene clusters would
share some equivalent genes for indolocarbazole core(1) in accession number A60304—gene 2 (putative sugar
N-methyltransferase), gene 5 (putative sugar amino- biosynthesis, we decided to perform a detailed se-
quence analysis of the staurosporine DNA sequence.transferase), and three ORFs with no proposed function
(genes 1, 3, and 4); (2) in accession number A60301— This analysis revealed a 5-truncated ORF, previously
not reported, at an end of the staurosporine sequencegene 1 (sugar O-methyltransferase) and gene 2 (putative
Table 3. Deduced Functions for Genes in the Rebeccamycin Gene Cluster
Gene Amino Acids Closest Similar Protein (% Identity/Similarity), Accession Number Proposed Function
orfD13 44a – unknown
orfR5 1003 regulatory protein AfsR from Streptomyces coelicolor (36/49), regulatory protein
P25941
orfR4 210 putative dipeptidase SCC53.19 from S. coelicolor (52/63), D-alanyl-D-alanine dipeptidase
CAB93448
orfD1 472 hypothetical protein SC6E10.10 from S. coelicolor (31/48), secreted esterase
CAB51964
orfR3 133 – unknown
orfD2 395 hypothetical protein CC0823 from Caulobacter crescentus (53/66), unknown
AAK22808
rebG/ngt 421 probable glycosyltransferase from Deinococcus radiodurans N-glycosyltransferase
(45/57), F75587
rebO 473 L-amino acid oxidase AIP from Scomber japonicus (29/44), L-amino acid oxidase
CAC00499
rebD 1013 VioB from Chromobacterium violaceum (34/47), AAD51809 bis-indole formation
rebC 529 2.4-dihydroxybenzoate monooxygenase from Sphingomonas sp. FAD-containing
(32/46), CAA51370 monooxygenase
rebP 397 cytochrome P450 YjiB from Bacillus subtilis (37/53), O34374 P450 heme-thiolate protein
rebM 273 methyltransferase from Amycolatopsis mediterranei (50/66), methyltransferase
AAC01738
rebR 923 transcriptional activator NysRI from Streptomyces noursei (25/35), regulatory protein
BAB50206
rebF 170 putative FMN:NADH oxidoreductase Gra-orf34 from flavin reductase
S. violaceoruber (39/52), CAA09661
rebU 426 putative integral membrane ion antiporter from A. orientalis integral membrane transporter
(40/54), CAB45049
rebH 530 tryptophan halogenase PrnA from Pseudomonas chlororaphis FADH2-dependent halogenase
(55/72), AAD46360
rebT 473 putative antibiotic antiporter FrnF from S. roseofulvus integral membrane transporter
(44/62), AAC18101
orfD12 81a hypothetical transcriptional regulator from M. tuberculosis regulatory protein
(43/63), Q10810
a Incomplete ORF.
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(nt 1–332 of accession number A60304). The deduced the deduced products of ngt and rebG differ in eight
amino acid residues, and RebG includes six additionalproduct of this ORF showed similarity to the C termini
of C. violaceum VioB (48% identity, 57% similarity) and residues at its C terminus. Some of the discrepancies
in the ngt/rebG flanking sequences also affect orfD2of RebD (63% identity, 70% similarity). The presence of
a vioB/rebD homolog in the violacein, staurosporine, and rebO, genes not previously defined, and make them
unfunctional in the published ngt sequence [9]. Afterand rebeccamycin gene clusters reinforces the idea of
its involvement in the condensation of two tryptophan- rechecking and confirming our sequence, we find it plau-
sible that these discrepancies originate from sequenc-derived units.
Two of the identified genes, rebC and rebP, could be ing errors in the published ngt sequence. So, from now
on we use the name rebG for the corrected sequenceinvolved in oxidative conversion of the first bis-indole
intermediate into the indolocarbazole core. Analysis of of the previously known ngt gene. RebG belongs to
“family 1” of NDP-sugar glycosyltransferases [30]. TherebC gene product showed an N-terminal FAD binding
domain [23] and clear similarities to a family of FAD- highest similarities were found to a probable glycosyl-
transferase from Deinococcus radiodurans (accessioncontaining, NAD(P)H-dependent monooxygenases act-
ing on aromatic compounds [24]. The highest similarities number F75587) and zeaxanthin glucosyl transferase
CrtX from Synechocystis sp. (accession number S74500).were found to 2,4-dihydroxybenzoate monooxygenase
DxnD from Sphingomonas sp. [25] and to putative po- It has been previously shown that rebG (ngt) encodes
an N-glycosyltransferase that, when expressed inlyketide hydroxylase SchC from Streptomyces halstedii
[26]. DxnD exhibits NADH oxidation activity with 2,4- S. lividans, is able to introduce a D-glucose moiety into
indolocarbazoles J-104303 and 6-N-methylarcyriaflavindihydroxybenzoate and is believed to catalyze decar-
boxylating monooxygenation to yield hydroxyquinol as C [9]. We propose that the physiological function of
RebG in Saccharothrix aerocolonigenes is the catalysisa product [25]. In our above-mentioned analysis of the
staurosporine DNA sequence, we also found a pre- of an N-glycosidic bond between a nucleotide-activated
D-glucose and the rebeccamycin indolocarbazole coreviously unreported ORF (nt 1845–2122 of accession
number A60301, plus nt 1–1373 of accession number (Figure 3).
A methylation step is required to yield the 4-O-methyl-A60305) whose deduced product showed similarities to
the same family of monooxygenases, including Sphin- D-glucose moiety present in rebeccamycin. The de-
duced product of rebM is similar to S-adenosylme-gomonas sp. DxnD (32% identity, 47% similarity) and
RebC (63% identity, 71% similarity). According to this, thionine-dependent methyltransferases, including a
methyltransferase from Amycolatopsis mediterraneia monooxygenase such as RebC could catalyze decar-
boxylative monooxygenations, as shown for Sphingo- (accession number AAC01738) and MitM from Strepto-
myces lavendulae [31]. RebM is also similar to sugarmonas sp. DxnD [25]. On the other hand, rebP gene
product is homologous to P450 heme-thiolate proteins methyltransferases deduced from the reported stauro-
sporine DNA sequence: O-methyltransferase encoded[27]. The highest similarities were found to a putative
cytochrome P450 YjiB from Bacillus subtilis (accession by gene 1 of accession number A60301, nt 845–1684
(36% identity, 53% similarity), and putative N-methyl-number O34374) and a probable cytochrome P450 hy-
droxylase from S. coelicolor (accession number T36526). transferase encoded by gene 2 of accession number
A60304, nt 1747–2553 (43% identity, 58% similarity).In our analysis of the staurosporine DNA sequence, we
found that the deduced product of accession number RebM could catalyze a methylation at the 4-hydroxy
position of a D-glucose moiety, probably after the glyco-A60304 “gene 1” (nt 378–1655), of unreported function,
was also similar to P450 heme-thiolate proteins, includ- sylation step during rebeccamycin biosynthesis (Fig-
ure 3).ing B. subtilis YjiB (32% identity, 51% similarity) and
RebP (51% identity, 60% similarity). It is worth men- Chlorination in the rebeccamycin pathway is probably
carried out by the rebH gene product. RebH resemblestioning that some P450 enzymes are able to form new
C-C or C-O bonds between aromatic moieties by phenol FADH2-dependent halogenases [7], including trypto-
phan halogenase PrnA from Pseudomonas spp. andoxidative coupling [28, 29]. One may hypothesize that,
in an analogous way, RebP could catalyze oxidative Myxococcus fulvus [32] and putative tryptophan halo-
genases from Caulobacter crescentus [17]. PrnA re-ring closure of a bis-indole intermediate to form the
indolocarbazole core. quires FADH2, O2, and chloride ions to regioselectively
convert tryptophan into 7-chlorotryptophan. FADH2 isGenes Probably Involved in Indolocarbazole
Modification provided by a flavin reductase that reduces FAD with
the help of NADH and that can be substituted by theAfter (or during) formation of the indolocarbazole core,
additional reactions must occur to arrive at the final corresponding enzyme from other organisms [7]. Re-
beccamycin is chlorinated precisely at indole positionsrebeccamycin molecule. These would include glycosyl-
ation and halogenation. A gene encoding an indolocar- equivalent to that of 7-chlorotryptophan. This halogena-
tion reaction could be catalyzed by RebH, either onbazole N-glycosyltransferase, ngt, has been previously
identified from Saccharothrix aerocolonigenes [9]. A tryptophan or on a later intermediate during rebecca-
mycin biosynthesis (Figure 3, see below). Chloride ionscomparison of the 1898 nt DNA sequence reported for
ngt (accession number AB023953) [9] and the corre- may be substituted by bromide ions for RebH halogena-
tion because bromoindolocarbazole compounds can besponding sequence determined by us (complementary
to nt 7484–9390 of accession number AJ414559) re- isolated from cultures of Saccharothrix aerocolonigenes
supplemented with potassium bromide [33].vealed several discrepancies in ngt/rebG coding se-
quence and also in flanking sequences. In particular, The deduced product of rebF belongs to a family of
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Figure 3. Proposed Biosynthetic Pathway for Rebeccamycin
The relative order of some reactions, such as the halogenation step, may well be different from the one presented here.
flavin:NAD(P)H reductases, the majority of which are proteins, which contain 10–12 transmembrane regions
at the N terminus and a large cytoplasmic region at thepart of two-component flavin-diffusible monooxygen-
ase systems [34]. Highest resemblances were found to C terminus [39]. Characterized members of this family
function as antiporters of Na (or K) and H and play aActVB homologs from S. violaceoruber (Gra-orf34) [35],
S. roseofulvus (FrnH) [36] and S. coelicolor (ActVB) [37], key role in maintaining cellular pH and other processes.
RebU was found to be most similar to a putative integraland to StyB protein from Pseudomonas fluorescens [38].
ActVB ( ActI-ORF6) is a flavin:NADH oxidoreductase membrane ion antiporter from Amycolatopsis orientalis
(accession number CAB45049) and putative antibioticthat participates in the last step of actinorhodin biosyn-
thesis, a symmetrical dimerization of two benzoquinone transporter AviJ from S. viridochromogenes [40]. Very
recently, a similar protein (ComF) has been found en-units by a phenolic oxidative coupling. ActVB probably
supplies reduced FMN to another as-yet-unknown en- coded in the complestatin biosynthetic gene cluster of
S. lavendulae [41].zyme directly involved in oxidative chemistry [37]. On
the other hand, StyB is a part of stirene monooxygenase, The rebT gene product, the second candidate for re-
beccamycin resistance and/or secretion, belongs to thea two-component system (StyAB) responsible for the
transformation of stirene to epoxystirene [38]. We pro- major facilitator family of integral membrane transport-
ers, responsible for antibiotic or antiseptic efflux with thepose that RebF and RebH form a two-component halo-
genase system, in which RebF supplies the reduced, aid of transmembrane electrochemical gradients [42].
Highest similarities were detected to putative antibioticdiffusible flavin that RebH needs to function (Figure 3).
Very recently, a pair of rebF-rebH homologs has been antiporter FrnF from S. roseofulvus [36] and to putative
efflux protein EncT from S. maritimus [43]. Plasmidfound to be linked in the genome of S. albogriseolus,
producer of the halogenated metabolite thienodolin pCS006, which contained rebT, was introduced in
S. albus and was found to confer resistance to rebecca-(Corina Schmid, personal communication). However, an
additional role for RebF in supplying reduced flavin to mycin.
Concerning regulation, we found that rebR gene prod-other rebeccamycin enzymes (RebO, RebC) cannot be
ruled out. uct belongs to subfamily LAL of regulatory proteins of
the LuxR family, involved in ATP-dependent transcrip-Genes Probably Involved in Resistance
and Regulation tional activation [44]. LAL proteins contain an N-terminal
ATP binding domain and a C-terminal LuxR-type DNATwo genes, rebU and rebT, could participate in rebecca-
mycin resistance and/or secretion. The deduced prod- binding domain. RebR shows low end-to-end similari-
ties to LAL proteins, including transcriptional activatoruct of rebU is similar to Na/H exchange membrane
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NysRI from Streptomyces noursei [45]. We propose that
RebR could function as a transcriptional activator of the
expression of rebeccamycin biosynthetic genes, and
some experimental evidence (see below) points toward
this idea.
Genes Probably Not Involved in Rebeccamycin
Biosynthesis
Results from database searching were not significant
enough for us to propose functions for orfD13, orfR3,
and orfD2. On one hand, deduced gene products of
orfD13 (truncated) and orfR3 did not have any homologs
in the databases, so their possible functions are un-
known. On the other hand, OrfD2 is similar to conserved
hypothetical proteins from several bacteria, includ-
ing CC0823 from Caulobacter crescentus [17] and
SCF41.20c from S. coelicolor [21]. It also shows weak,
limited similarities to putative 2-hydroxyhepta-2,4-
diene-1,7-dioate isomerases such as BH2000 from Ba-
cillus halodurans [46], but at the moment we do not feel
this is enough to propose a function for OrfD2.
Deduced products of another group of ORFs (orfR5,
orfR4, and orfD1) showed similarities to proteins of
known functions, but these proteins are apparently unre-
lated to rebeccamycin biosynthesis. OrfR5 resembles
AfsR, a global regulatory protein conditionally required
for secondary metabolism in S. coelicolor [47]. OrfR4 is
similar to putative dipeptidase SCC53.19 from S. coeli-
color [21] and to Synechocystis sp. confirmed D-alanyl-
D-alanine dipeptidase SynVanX, probably having a role
in cell-wall turnover [48]. Finally, the deduced product
of orfD1 is probably a secreted protein with a signal
peptide cleaved between amino acids 47 and 48 (as
predicted by the SignalP program [49]) and resembles
hypothetical protein SC6E10.10 from S. coelicolor [21]
and fusidic-acid esterase FusH, an extracellular enzyme
from S. lividans [50].
At the right end of the sequenced region (Figure 2A),
orfD12 (incomplete) encodes the N-terminal part of a
protein homologous to MarR family regulatory proteins,
many of which respond to phenolic compounds [51].
Highest similarities were found to hypothetical tran-
scriptional regulators Rv2887 from Mycobacterium tu-
berculosis [52] and SC1A4.04 from S. coelicolor [21].
The involvement of OrfD12 in gene regulation for rebec-
camycin biosynthesis is unclear because rebeccamycin
Figure 4. Heterologous Expression of Selected Subsets of Genes
genes are efficiently expressed from cosmid 14E8, in from the Rebeccamycin Cluster
which orfD12 is truncated. HPLC analysis of extracts from (A) S. albus J1074/pREB5 (the control
S. albus J1074/pEM4 showed an identical chromatogram), (B)
S. albus J1074/pREB6, and (C) S. albus J1074/pREB7. The elution
Production of Rebeccamycin Derivatives time of rebeccamycin, used as a standard and previously purified
from Saccharothrix aerocolonigenes, is indicated by an arrow.in a Heterologous Host
Chemical structures of compounds 1–4 are shown in Figure 1.In order to confirm some of the gene functions deduced
by sequence analysis and to produce some rebecca-
mycin biosynthetic intermediates, we constructed sev-
eral plasmids containing fragments of cosmid 14E8 (Fig- the gene functions present in pREB5, it was expected
that the plasmid would direct the biosynthesis of des-ure 2B). These multicopy plasmids were introduced into
S. albus J1074 and, after cultivation of these recombi- chloro-rebeccamycin. However, transformants S. albus
J1074/pREB5 did not produce any detectable indolocar-nant strains in the presence of thiostrepton (resistance
marker in the vector), extracts of the new strains were bazole (Figure 4A). Because this could have been a con-
sequence of some missing regulatory factor causinganalyzed by HPLC for production of indolocarbazole
derivatives. The first plasmid, pREB5, contained genes poor expression of the cloned genes, two new plasmids,
pREB6 and pREB7, were constructed (Figure 2B). Plas-rebG, rebO, rebD, rebC, rebP, and rebM, with their own
promoter and/or regulatory sequences. On the basis of mid pREB6 contained genes rebO, rebD, rebC, rebP,
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and rebM, under the control of the strong and constitu- The third isolated compound was a minor rebecca-
tive promoter ermE*p [53], so it was expected to direct mycin derivative that had a demethylated sugar residue
the biosynthesis of nonchlorinated rebeccamycin agly- and also lacked both chlorine atoms. This follows from
cone. Plasmid pREB7 included genes rebG, rebO, rebD, a high-resolution EI-MS experiment, in which the com-
rebC, rebP, rebM, rebR, rebF, and a 3-truncated rebU, pound gave a molecular ion with m/z ratio of 487.1378,
and we expected it could produce deschloro-rebecca- and the prominent aglycone peak at m/z 325 found also
mycin. HPLC analysis (Figures 4B and 4C) of extracts in the MS spectra of all the other analyzed products.
from transformants S. albus J1074/pREB6 and S. albus The high-resolution mass of 487.1378 is in agreement
J1074/pREB7 indeed revealed three new products with with the calculated mass for C26H20N3O7 of 487.1380.
characteristic indolocarbazole absorption spectra. Unlike rebeccamycin, the compound lacks both chlorine
These new biosynthetic products were purified by atoms because both the 1-H and the 11-H signals are
preparative HPLC and characterized by high-resolution present in the 1H NMR spectrum. Also obvious from the
MS and NMR, confirming them as being deschloro- 1H NMR spectrum was that the O-methyl group in the
rebeccamycin aglycone (from S. albus J1074/pREB6), 4 position is missing. Instead, a new hydroxyl group at
deschloro-rebeccamycin, and demethyl-deschloro-  5.34 (4-OH) was found in close proximity to 4-H (
rebeccamycin (the last two products are from S. albus 3.96), as indicated by the H,OH coupling observable in
J1074/pREB7), respectively (Figure 1). the 1H- and H,H-DQCOSY spectrum. A coupling between
The putative aglycone showed a main peak with an 4-OH and C4 (C 68.2) was also detected in the HMBC
m/z value of 325.0845, which corresponds to the calcu- spectrum. All other signals are very similar to those
lated molecular mass of the nonchlorinated, deglycosy- of compound 2. Also, the 13C NMR spectrum (Table 1,
lated rebeccamycin derivative, 325.0851. Interestingly, compound 3) of this third new compound is very similar
this ion was also present in the spectra of all the other to the one of deschloro-rebeccamycin; the only differ-
products analyzed in this study. The 13C NMR experi- ences are that the signal of C4 ( 68.2) is shifted upfield
ment showed only ten signals, as expected because of approximately 10 ppm, in agreement with the a missing
the symmetry of the molecule (Table 1, compound 4), OCH3 group in this position, and that there is no signaland none of the typical carbohydrate carbons with  in from an OCH3 group. These data in combination withthe range of 60–90 was present in the spectrum of this the high-resolution MS data prove that this third com-
compound. The HSQC and HMBC experiment allowed pound is indeed 4-demethyl-deschloro-rebeccamycin
the assignments of most carbons; however, the assign-
(3). The occurrence of a minor rebeccamycin derivative
ments of C1 and C4 and those of C2 and C3 may be
that is glycosylated and not methylated may seem illogi-
interchanged. The integrals of the 1H NMR spectrum
cal because plasmid pREB7 included the putative meth-along with the MS data clearly reveal the symmetry of
yltransferase gene rebM. However, similar results havethe molecule because each signal corresponds to two
been previously obtained when Saccharothrix aeroco-protons, except the one of the central N6-H. The pres-
lonigenes ATCC39243 was fed with unnatural sub-ence of the new doublet at  8.96 (d, 2H, 1-H, and 11-H),
strates; bioconversion of indolocarbazole aglyconewhich is part of an ABCD system, proves that the aro-
J-104303 yielded the corresponding glycosylated (butmatic rings contain here four adjacent protons, which
not methylated) compound [9], and feeding eitherproves that no chlorine atoms are any longer attached
5-fluorotryptophan or 6-fluorotryptophan resulted in pro-to the 1 and 11 positions. Thus, the NMR data also
duction of the corresponding fluorinated 4-demethyl-confirm the proposed structure, deschloro-rebacca-
deschloro-rebeccamycins or a mixture of both methyl-mycin aglycone (4, Figure 1).
ated and nonmethylated derivatives [18].The second compound gave a molecular ion with a
The fact that deschloro-rebeccamycin was producedhigh-resolution m/z ratio of 501.1543, which is in agree-
by a strain harbouring pREB7, but not by a strain car-ment with the molecular mass of deschloro-rebecca-
rying pREB5, suggests that transcription of rebODCPMmycin (calculated for C27H23N3O7: 501.1536). The broad-
probably needs to be activated by the rebR product. Inband-decoupled 13C NMR spectrum of the compound
the case of pREB6, the strong promoter ermE*p over-shows all the expected signals; most of the assignments
comes this problem because of its constitutive expres-were deduced from the comparison with rebeccamycin
sion. However, rebG transcription might not need to beand from the 2D homonuclear and heteronuclear corre-
activated by RebR because rebG (ngt) was expressedlation experiments (HSQC, HMBC, and DQCOSY, Table
in S. lividans without any additional promoters [9], al-1). As indicated from the NMR data, a 4-O-methyl glu-
though this could also be explained by read-throughcose residue was clearly present in the structure of the
transcription from vector promoter sequences. Themetabolite. The data show in particular that the com-
structures of the isolated rebeccamycin derivatives rein-pound contains only two nitrogen bound protons (N13-H
force the functions proposed for the reb genes fromand N6-H); the latter shows—as in all compounds de-
sequence analysis and database comparisons.scribed here—a strong coupling with the characteristic
Other laboratories have previously used chemical syn-carbonyl signal at C 171 in the HMBC spectrum. Also,
thesis or hemisynthesis to obtain compounds structur-the usual cross peaks of N13-H with C12b/C13a were
ally identical to nonchlorinated rebeccamycin aglyconeobserved, as well as the couplings of C1-H of the 4-O-
and deschloro-rebeccamycin [6]. These authors ana-methyl glucose moiety with C12a and C11a. The protons
lyzed the biological activities of these compounds inattached at C1 and C11 ruled out the presence of chlo-
antimicrobial and antiproliferative tests, as well as inrine atoms at the corresponding positions. These data
inhibition assays toward protein kinases C (PKC) and Acombined with the MS data prove the structure of
deschloro-rebeccamycin (2, Figure 1). (PKA) and topoisomerases I (Topo I) and II (Topo II) [6,
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12]. No inhibition of Topo II was detected with any of for anticancer chemotherapy, based on their activity
as inhibitors of DNA topoisomerases or protein ki-the two compounds, as is the case for rebeccamycin
itself. Nonchlorinated rebeccamycin aglycone did not nases. Additionally, a great interest is focused on the
synthesis of a growing number of new indolocarbazoleshow any antimicrobial activity against the different mi-
croorganisms tested, including two Streptomyces spp. analogs with promising anticancer, antiviral, antifun-
gal, antihypertensive, or neuroprotective activities.[12]. This result may explain why strain S. albus J1074/
pREB6 is able to produce this compound and survive, Complementary to the efforts in chemical synthesis,
the genetic manipulation of genes governing indolo-despite the fact that no rebeccamycin resistance or
transporter gene is included in pREB6. In the same re- carbazole biosynthesis offers a promising alternative
for preparation of these compounds. This work repre-port, dechlorinated rebeccamycin showed no growth-
inhibitory effect against the microorganisms tested, with sents the first characterization of a complete gene
cluster governing the biosynthesis of an indolocarba-the only exception being a very weak activity toward
one of the two Streptomyces spp. assayed [12]. Strain zole metabolite, rebeccamycin. Our results are consis-
tent with precursor incorporation studies showing thatS. albus J1074/pREB7 may be protected from the
weakly toxic effects of deschloro-rebeccamycin by a rebeccamycin is biosynthetically derived from two
units of L-tryptophan, one D-glucose, and one3-truncated rebU, included in pREB7, which encodes
an almost complete putative transporter (lacking only L-methionine in Saccharothrix aerocolonigenes. Sev-
eral genes encoding enzymes with unusual or poorly13 amino acids) that could participate in metabolite se-
cretion/resistance. Interestingly, when compared to re- understood activities have been identified, among
them those involved in bis-indole/indolocarbazole for-beccamycin, dechlorinated rebeccamycin showed a
higher inhibitory activity toward Topo I and similar in mation, N-glycosylation, and halogenation. In addition,
genes responsible for indolocarbazole core formationvitro antiproliferative activity against murine B16 mela-
noma and P388 leukemia cells [6]. From the study of a are of special interest because they might be useful
as probes for identifying related natural-product bio-range of glycosylated and nonglycosylated rebecca-
mycin semi-synthetic derivatives, it has been concluded synthetic genes from other organisms. The availability
of the reb gene cluster should facilitate future at-that the presence of the chlorine atoms on the indole
residues is detrimental to both PKC and Topo I inhibitory tempts, using combinatorial biosynthesis and rational
metabolic pathway engineering, to produce novel in-activities [6]. In this respect, we have shown in this work
that the expression of some rebeccamycin biosynthetic dolocarbazoles with improved, or even new, therapeu-
tic activities. The advantage of having this informationgenes allows the formation of three nonchlorinated re-
beccamycin derivatives that are potentially useful as has already been demonstrated through heterologous
expression of (1) the complete gene cluster, whichlead compounds for further drug development. It is also
worth mentioning that nonchlorinated rebeccamycin provided a several-fold increase in rebeccamycin pro-
duction and (2) selected subsets of genes, which al-aglycone has comparatively poor antiproliferative and
anti-Topo I activities, but it shows some inhibition to- lowed us to obtain three different rebeccamycin-
related compounds.ward PKC and PKA (whereas neither rebeccamycin nor
dechlorinated rebeccamycin inhibit protein kinases). In
Experimental Proceduresthis sense, it seems that the sugar residue attached to
the indolocarbazole chromophore is critical for the drug
Bacterial Strains, Culture Conditions, and Vectorsability to interfere with Topo I as well as for the formation
Saccharothrix aerocolonigenes ATCC39243, Streptomyces albus
of intercalation complexes with the DNA [6]. Further- J1074 [58], Escherichia coli XL1-Blue [59], E. coli ED8767 [60], and
more, nonchlorinated rebeccamycin aglycone is struc- Micrococcus luteus ATCC1024 were used in this work. Vectors
pKC505 [10], pWHM3 [61], and pEM4 [62] have been describedturally identical to arcyriaflavin A, a natural product iso-
previously, and LITMUS 28 (New England BioLabs) was from a com-lated from the slime mold Arcyria denudata [54] and
mercial source. Shuttle vector pUWL201 was obtained from U. Weh-the marine ascidian Eudistoma sp. [55]. Recently, it has
meier and W. Piepersberg (Wuppertal, Germany). For sporulation,been reported that arcyriaflavin A is a potent inhibitor
Saccharothrix aerocolonigenes and S. albus were routinely grown
of human cytomegalovirus replication in cell culture, for 7 days at 30C on agar plates containing either A medium [63]
which could eventually lead to a new class of drugs or Bennett’s agar [64]. When antibiotic selection of transformants
was needed, 100 g/ml ampicillin, 25 g/ml thiostrepton (5 g/ml[56, 57].
in liquid media), 25 g/ml apramycin, or 20 g/ml tobramycin wasWith the present work, the utility of manipulating the
used.rebeccamycin biosynthetic genes to produce a variety
of indolocarbazole compounds with different biological
DNA Manipulationproperties becomes clear. Further experiments are now
Total DNA isolation, plasmid DNA preparations, restriction endonu-
in progress to produce novel indolocarbazole deriva- clease digestions, ligations, and other DNA manipulations were per-
tives and to achieve a better understanding of the bio- formed according to standard procedures for E. coli [65] and for
Streptomyces [64]. A genomic library of Saccharothrix aerocoloni-chemical processes involved in rebeccamycin biosyn-
genes was constructed in pKC505 according to literature proce-thesis.
dures [10] and screened with a probe made from the N-glycosyl-
transferase gene, ngt [9]. This probe was obtained by polymerase
chain reaction (PCR) according to standard procedures. Total DNASignificance
from Saccharothrix aerocolonigenes with oligoprimers CS003 (5-
TAGAATTCATCGAACCCGCGGCC-3, altered sequence in italics,
Several indolocarbazoles derived from natural prod- EcoRI underlined) and CS004 (5-TATAAGCTTCGGCTGCCA
GCGCTC-3, altered sequence in italics, HindIII underlined), de-ucts are presently undergoing phase I/II clinical trials
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signed to amplify a DNA fragment encompassing nt 552–1146 from Isolation of Rebeccamycin and Related Compounds
Spores of strains S. albus J1074/14E8, S. albus J1074/pREB6, andthe published ngt sequence, was used [9]. Digoxigenin labeling of
DNA probes, Southern analysis, hybridization, and detection were S. albus J1074/pREB7 were inoculated in TSB medium (Oxoid) and
incubated for 24 hr at 30C and 250 rpm. Each seed culture wasperformed according to literature procedures [65] and manufacturer
recommendations (Boehringer Mannheim). Transformation of used to inoculate (at 2.5%, v/v), eight 2 liter Erlenmeyer flasks con-
taining 400 ml of R5A medium (described as “modified R5 medium”S. albus protoplasts followed procedures routinely used for Strepto-
myces [64]. in [63]). After incubation for 5 days in the above conditions, the
cultures were centrifuged (12,000 rpm, 30 min). In the cultures ofPCR amplification of halogenase-encoding regions was per-
formed with degenerate oligoprimers trpst (5-TATCGGATCCGG strain S. albus J1074/pREB7, rebeccamycin-related compounds
were found both in the supernatants and in the pellets, whereas inSTGGACCTGGRASATYCC-3, S  (C, G), R  (A, G), Y  (C, T),
BamHI site underlined) and trpst- (5-AGTTGGTACCGSGCSGCG the other two strains these compounds were largely associated with
the pellets; therefore, their supernatants were discarded. The pelletsTASAKGAAGTA-3, K  (G, T), KpnI site underlined), as previously
described [11]. corresponding to each strain were extracted with 400 ml acetone
and shaken for 2 hr, after which the suspensions were centrifuged
and the organic extract was evaporated in vacuo. The S. albus
Construction of Plasmids J1074/pREB7 culture supernatant was filtered and applied to a
Cosmid 14E8 was partially digested with BglII and EcoRI, and frag- solid-phase extraction cartridge (Sep-Pak Vac 35 cc, Waters). The
ments were subcloned in LITMUS 28, yielding (among others) plas- retained material was eluted with methanol and water, with a linear
mids pREB1, pCS002, pCS003, and pCS004. One of the resulting gradient from 0% to 100% methanol in 1 hr at 10 ml/min. Fractions
plasmids, pREB1, contained a BglII-EcoRI DNA fragment encom- were taken every 5 min and analyzed by HPLC. The rebeccamycin-
passing nt 7,119–17,783 of the sequenced region. This 10.6 kb DNA related compounds produced by this strain eluted in the fraction
fragment was obtained from pREB1 as a SpeI-EcoRI fragment and taken between 40 and 45 min, which was evaporated in vacuo.
transferred into the XbaI-EcoRI sites of pWHM3, yielding plasmid For purification, the material extracted from pellets of each strain
pREB5. Plasmid pCS002 contained a BglII-EcoRI DNA fragment was redissolved in 5 ml of a mixture of DMSO and acetone (50:50).
encompassing nt 8,562–17,783 of the sequenced region. This 9.2 The extract from strain S. albus J1074/14E8 was chromatographed
kb DNA fragment was obtained from pCS002 as a BglII-EcoRI frag- in a Bondapak C18 radial compression cartridge (PrepPak Car-
ment and transferred into the BamHI-EcoRI sites of pEM4, yielding tridge, 25 	 100 mm, Waters) via isocratic elution with acetonitrile
plasmid pREB6. Plasmids pCS003 and pCS004 contained, respec- and water (55:45) at 10 ml/min. The extract from strain S. albus
tively, an EcoRI-BglII DNA fragment (nt 17,783–20,425) and a BglII- J1074/pREB6 was chromatographed in a semipreparative column
EcoRI DNA fragment (nt 20,425–22,241). These two DNA inserts (XTerra RP18, 7.8	 300 mm, Waters) via isocratic elution with meth-
were obtained from pCS003 and pCS004 as EcoRI-BglII and BglII- anol and water (90:10) at 3 ml/min. The material extracted from
EcoRI fragments, respectively, and ligated to EcoRI-digested either the pellets or the broth of strain S. albus J1074/pREB7 was
pREB5, resulting in plasmid pREB7. chromatographed on the semipreparative column mentioned above
Plasmid pCS006 was generated by cloning an EcoRI-XbaI DNA and eluted with acetonitrile and water (50:50) in isocratic conditions.
fragment from cosmid 14E8 into vector pUWL201. This fragment, The compounds collected in every case after multiple injections
which included rebT, spanned from nt 22,241 to the end of the insert were dried in vacuo and finally lyophilized.
(nt 25,681) plus 500 bp from pKC505.
MS and NMR Methods
DNA Sequencing and Analysis NMR spectra were recorded in d6-DMSO on a Varian Inova 400
DNA sequencing was performed on double-stranded DNA tem- instrument at 400 MHz for 1H and 100.6 MHz for 13C by the use of
plates in pUC18 with the dideoxynucleotide chain termination 1D spectra and 2D homo- and heteronuclear correlation experi-
method [66] and the Cy5 AutoCycle Sequencing Kit (Pharmacia ments (1H, 13C, H,H-COSY, HSQC, and HMBC).
Biotech). An ALF-express automatic DNA sequencer (Pharmacia) Electron ionization mass spectrometry (EI-MS) was used to deter-
was used to sequence both DNA strands with primers supplied mine the mass of the purified compounds. The high-resolution elec-
in the kit or with internal oligoprimers (17-mer). Computer-aided tron ionization (HR-EI) mass spectra were acquired at the University
database searching and sequence analysis were carried out with of South Carolina, Department of Biochemistry and Chemistry facili-
the University of Wisconsin Genetics Computer Group software [67] ties in Columbia, SC with a VG70SQ double focusing magnetic sec-
and the BLAST program [68]. tor MS instrument.
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